Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection.
about
Immune Checkpoint Modulators: An Emerging Antiglioma ArmamentariumSeverity, etiology and possible consequences of treatment-related lymphopenia in patients with newly diagnosed high-grade gliomasAdoptive cell therapies for glioblastomaSupportive management of patients with brain tumors.Prognostic value of the preoperative immunological profile in patients with glioblastoma.Combination of temsirolimus (CCI-779) with chemoradiation in newly diagnosed glioblastoma multiforme (GBM) (NCCTG trial N027D) is associated with increased infectious risksImmune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme.PMA and ionomycin induce glioblastoma cell death: activation-induced cell-death-like phenomena occur in glioma cellsImmunosuppression in patients with high-grade gliomas treated with radiation and temozolomideClinical benefit in recurrent glioblastoma from adjuvant NovoTTF-100A and TCCC after temozolomide and bevacizumab failure: a preliminary observation.Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma.Treatment-related lymphopenia in patients with stage III non-small-cell lung cancer.Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*.Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomas.The association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreas.Patterns of Radiation-Associated Lymphopenia in Children with CancerLymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic CancerCytomegalovirus associated colonic pseudotumor: a consequence of iatrogenic immunosuppression in a patient with primary brain tumor receiving radiation and temozolomide.Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy.Sustained CD4(+) T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomide.The future of glioblastoma therapy: synergism of standard of care and immunotherapy.Managing Disease and Therapy-Related Complications in Patients with Central Nervous System Tumors.The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells.Herpes simplex encephalitis in a patient with recurrent pituitary adenoma receiving radiation therapy.Fatal herpetic encephalitis during brain radiotherapy in a cerebral metastasized breast cancer patient.Tuberculosis in a patient on temozolomide: a case report.Long-term survival in AIDS-related primary central nervous system lymphoma.Dapsone induced methemoglobinemia in a patient with glioblastoma.Severe pneumocystis jiroveci pneumonia in a patient on temozolomide therapy: A case report and review of literature.Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone.Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma.Response to: Comment on 'Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma'.[Requirements for hygiene in the medical care of immunocompromised patients. Recommendations from the Committee for Hospital Hygiene and Infection Prevention at the Robert Koch Institute (RKI)].Infections in neuro-oncology.Decreased rate of infection in glioblastoma patients with allelic loss of chromosome 10q.Cryptococcal meningitis in patients with glioma: a report of two cases.Impact of concurrent versus adjuvant chemotherapy on the severity and duration of lymphopenia in glioma patients treated with radiation therapy.Pneumocystis jiroveci pneumonia (PJP) in non-HIV immunocompromised individuals.Kitten-transmitted Bordetella bronchiseptica infection in a patient receiving temozolomide for glioblastoma.Serial changes in lymphocyte subsets in patients with newly diagnosed high grade astrocytomas treated with standard radiation and temozolomide.
P2860
Q26765459-7C8603B4-63D2-46BD-842D-2562E22D0A39Q26862551-93D55606-C44A-40BF-854D-08993259601EQ27030863-65DEE9F5-92D8-4988-8916-1295CF79AAD0Q30444752-74022664-C5EB-4168-AE17-B8AE706FA9F8Q33887213-03CF3381-3139-49BC-BCAB-06CD928A1E76Q34316147-592C9246-DA04-400C-8D2C-DBC33DED5AF8Q34722857-B23F706D-3762-4FA5-8BC3-F66A7095CD2BQ35018554-5CCC9FA8-DDC1-48E9-B9D8-2D7410FF15C8Q35167257-CB6B84FA-1245-4346-9E79-5D01E426E531Q35236790-73252DF0-EE7C-4A6F-A34C-02556F519BD5Q35863183-12B722A2-5678-4BF7-827F-8BEFAF4CF1DFQ36130532-CB5A569D-A100-4CE4-A2F4-0E92EFA0AE8CQ36349776-CB659318-EF6F-4940-83F5-DE9E3DD6C4A4Q36416343-02740177-AB03-4D07-B4AF-BF2EBC9090A0Q36569129-D3BCCC4F-3C5B-4CD9-B7B2-348F9C294B43Q36663654-83780CB0-7092-4452-B0E1-657F1C2BF59CQ36842981-41FAA292-B492-4564-9B91-4083A7C1A8A9Q36968570-6E20D62C-82B7-457D-B20B-2F024ED4634AQ37154132-500870A5-0F2D-4204-B510-0A3D587580DBQ37732218-0F667C50-9A78-40EB-A127-43B291B7BCA2Q38255481-70A4B118-7A49-465F-9CF3-1D80961461A7Q38542829-2D205184-9FCE-414E-8F74-B9842EF50EF9Q38819926-558EB5E8-9403-465C-AD6F-4DE2AFAF2379Q38819946-C4050D6C-4973-4DF8-97D3-A0CBF84C66BCQ40366479-73395E71-D232-442D-953A-29FBF8958E40Q40405989-49DDE68C-309D-4773-9521-C4C11ED6D35EQ40557791-ECE4A1AC-F995-474B-911B-090A0F755CB7Q40892234-33DEA808-957B-4F18-8ED5-4708A4E49526Q41502821-09E6A3D1-7E83-4E17-9E2B-3D795C6BE578Q41826343-BB81A7D4-54E4-4805-BF72-DA3908E30528Q42204578-1BF805CF-D39F-480B-9E23-6D998B182829Q43099390-B535D39F-D7BE-4472-93A7-09309364E553Q43609178-674832AD-0DFF-4D36-BE96-16D6B003ADACQ44440017-3B9E5BD3-B715-48A3-93C6-7BF2D88957B0Q46412180-DFA0F927-86C8-4C7E-904D-4DAAA746D3EEQ46656232-980F35E2-91E9-4B0A-8655-FE597DAFB84CQ47577963-F36C22D4-FAED-407C-9725-B86ECA292869Q47937549-1F0E0AD0-C688-49D6-B52E-62B0DFAB3D10Q48103919-2B08CD77-0670-453F-B91E-F8AD32051676Q48325020-1C3FC31D-B1B2-4D0D-B856-018C1C99D6BA
P2860
Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Primary brain tumors treated w ...... counts and risk of infection.
@en
Primary brain tumors treated w ...... counts and risk of infection.
@nl
type
label
Primary brain tumors treated w ...... counts and risk of infection.
@en
Primary brain tumors treated w ...... counts and risk of infection.
@nl
prefLabel
Primary brain tumors treated w ...... counts and risk of infection.
@en
Primary brain tumors treated w ...... counts and risk of infection.
@nl
P2093
P1476
Primary brain tumors treated w ...... counts and risk of infection.
@en
P2093
Lawrence Kleinberg
Michael A Hughes
Michele Parisi
Stuart Grossman
P304
P356
10.1016/J.IJROBP.2004.12.085
P407
P577
2005-08-01T00:00:00Z